Harpoon Therapeutics Inc (HARP) Stock: What Does the Chart Say Friday?

Friday, February 23, 2024 02:20 PM | InvestorsObserver Analysts

Mentioned in this article

Harpoon Therapeutics Inc (HARP) Stock: What Does the Chart Say Friday?

Harpoon Therapeutics Inc (HARP) stock has gained 2.32% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Harpoon Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on HARP!

See Full HARP Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With HARP Stock Today?

Harpoon Therapeutics Inc (HARP) stock has fallen -0.07% while the S&P 500 is up 0.09% as of 2:18 PM on Friday, Feb 23. HARP has fallen -$0.01 from the previous closing price of $22.96 on volume of 1,075,406 shares. Over the past year the S&P 500 has gained 27.58% while HARP is up 186.88%. HARP lost -$8.71 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Harpoon Therapeutics Inc click here.

More About Harpoon Therapeutics Inc

Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others. Click Here to get the full Stock Report for Harpoon Therapeutics Inc stock.